| Objective: To observe the effects of Ligustrazine on patients with transient ischemicattack of cerebral blood flow velocity and microemboli number effect. Hope that throughobservation, ligustrazine in treating transient cerebral ischemic attack to provide clinicalbasis.Method: according to the criteria, a random sample of patients with transientischemic attack of60, were randomly divided into treatment group (30cases) andligustrazine group (30cases), before treatment were transcranial Doppler (TCD) andmicroemboli monitoring inspection. The basis of the treatment group (to aspirinBayaspirin)100mg Po Qd, clopidogrel (Plavix)75mg Po Qd, atorvastatin (Lipitor)20mg Po Qn calcium, Flunarizine Hydrochloride Capsules (sibelium)5mg Po Qn,ligustrazine group in foundation treatment group based on the use of injection ligustrazinehydrochloride (Chuan)0.24g250ml ivdrip Qd treatment in saline.4weeks aftertranscranial Doppler (TCD) and microemboli monitoring inspection, and usingSPASS17.0statistical analysis software on cerebral blood flow velocity and microembolinumber change.Results: statistical analysis of the results shows, before treatment and foundation ofLigustrazine group treatment group flow velocity and cerebral microemboli number nodifference (P>0.05), after treatment, two groups of cerebral blood flow velocity andmicroemboli number obviously different (P <0.05).Conclusions: intravenous infusion of Ligustrazine on improvement of transientischemic attacks in patients with cerebral blood flow velocity and microemboli number hasa notable curative effect. |
PDF Full Text Request